Scarica l'app Stockscreener
7.64
3.54%
-0.28
Dopo l'orario di chiusura:
7.64
Gri Bio Inc Borsa (GRI) Ultime notizie
Stock market today: Wah Fu Education Group +219.55%, Jet.AI +46.26% among top gainers in early trading - Business Upturn
GRI Bio announces 1-for-17 reverse stock split to regain Nasdaq compliance - MSN
GRI Bio Stock Set to Reverse Split on Monday, February 24th (NASDAQ:GRI) - Defense World
GRI Bio Announces Reverse Stock Split - GlobeNewswire
Can GRI Bio's 17:1 Reverse Split Save Its Nasdaq Listing? Key Details Revealed - StockTitan
GRI Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - GlobeNewswire
Vstock Transfer Announces Sponsorship of the Centri Capital Conference at Nasdaq - The Manila Times
Virtual Investor “Top 5 for ’25” Conference Hosted by JTC Now Available On-Demand - The State
GRI Bio, Inc. Highlights Key Investment Reasons at Virtual Investor Conference - Nasdaq
Inside GRI Bio's Ambitious NKT Cell Strategy: Can This Biotech Reshape Inflammatory Disease Treatment? - StockTitan
GRI Bio approves reverse stock split, stockholders vote in favor - MSN
MediWound stock climbs 4% on Phase 3 study initiation - MSN
GMR agree deal for Southern Brave to conclude Hundred sell-off - MSN
GRI Bio approves reverse stock split, stockholders vote in favor By Investing.com - Investing.com Australia
Cargill to take full control of Brazil's SJC Bioenergia - MSN
Analyzing the Price-to-Earnings Ratio of GRI Bio Inc (GRI) - The News Heater
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
BriaCell Therapeutics stock rises on positive clinical trial results - MSN
Phibro Animal Health (NASDAQ:PAHC) and GRI Bio (NASDAQ:GRI) Critical Review - Defense World
Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust - GlobeNewswire
SRIVARU Holding faces trading suspension after nasdaq delisting determination - MSN
JTC Team Announces Participating Company Line-Up for the Virtual Investor Pitch Conference on June 17-18, 2024 - ACCESS Newswire
IN8bio Inc (NASDAQ: INAB): What’s Next After The Stock Plunge? - Stocks Register
Windtree Therapeutics Appoints Leanne Kelly to Board of Directors and Audit Committee - Defense World
Windtree Therapeutics Appoints Leanne Kelly to Board, Advances New Growth Strategy - MyChesCo
Windtree Announces the Addition of Leanne Kelly to Its Board of Directors - The Manila Times
Windtree Therapeutics Strengthens Board with Biotech Finance Veteran Leanne Kelly - StockTitan
Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews
Pre-market Movers: HSDT, PBM, MTEM, APTO... - RTTNews
The GRI Marketing Group Joins SDL to Accelerate North America CX Growth Strategy - Yahoo Finance
Short Interest in GRI Bio, Inc. (NASDAQ:GRI) Increases By 155.5% - Defense World
FLYHT Aerospace Solutions Ltd. (OTCMKTS:FLYLF) Sees Significant Growth in Short Interest - Defense World
Viracta stock falls on strategic review (VIRX:NASDAQ) - Seeking Alpha
GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and - EIN News
GRI Bio Announces European Patent Office Issued a Decision - GlobeNewswire
GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and Its Library of 500+ Proprietary Compounds - GlobeNewswire Inc.
Mainz Biomed stock higher on Quest deal (MYNZ:NASDAQ) - Seeking Alpha
GRI Bio (NASDAQ:GRI) Now Covered by HC Wainwright - Defense World
GRI Bio Inc (NASDAQ: GRI): What’s Next After The Stock Plunge? - Stocks Register
Astera Labs Inc: Is ALAB Stock Worth Buying? - Stocks Register
Pre-market Movers: SXTC, STIM, BIOA, UPC... - RTTNews
GRI Bio to Participate in the Virtual Investor Closing Bell Series - GlobeNewswire
GRI Bio to Present Corporate Strategy at Virtual Investor Closing Bell Series - StockTitan
GRI Bio reports progress in IPF treatment with GRI-0621 - Investing.com India
GRI Bio Showcases GRI-0621’s Potential to Reduce - GlobeNewswire
GRI Bio's IPF Drug Shows Promise in Preclinical Data, Phase 2a Trial Underway | GRI Stock News - StockTitan
GRI Bio files to sell 1.58M shares of common stock for holders - MSN
SEC Form 424B3 filed by GRI Bio Inc. - Quantisnow
GRI Bio Inc (GRI) Quarterly 10-Q Report - Quartzy
GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis - GlobeNewswire
GRI Bio Raises $13.9M, Extends Runway for Key IPF Drug Trial Data in 2025 | GRI Stock News - StockTitan
GRI Bio Inc expected to post a loss of 73 cents a shareEarnings Preview - XM
Ascendiant Capital Initiates Coverage of GRI Bio (GRI) with Buy Recommendation - MSN
Beam Therapeutics (BEAM) Stock Surges with Strong Trading Volume - GuruFocus.com
Curis (CRIS) Stock Plummets Over 5% Amid Lack of Institutional R - GuruFocus.com
Wall Street Today: Amazon leads US stocks to rally amid rising yields; Exxon, Chevron top Q3 forecasts - Mint
3.13%
1.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):